Skip links

Antibody Engineering

Science & Technology

Engineering for Precision Therapeutics

At the forefront of what we are doing are our antibody engineering capabilities to design novel molecules that address inflammation and cancer.

OncoOne's Antibody Technology

The pioneers for oxMIF and wizards of antibody engineering are advancing precision medicine with cutting edge technologies. Monoclonal antibodies have revolutionized immunotherapy and are the preferred modalities to target cytokines and tumor antigens. Antibody engineering competencies are critical to optimize their therapeutic potential. At OncoOne, our world-class team of antibody engineers develop and optimize unique, tailored antibodies (mAbs) with precisely defined functionalities, specifically engineered for individual therapeutic indications.

OncoOne Antibody Engineering
OncoOne is pioneering two cutting-edge technology platforms that are unlocking a new era of therapeutic breakthroughs.

OncoOne is pioneering two cutting-edge technology platforms that are unlocking a new era of therapeutic breakthroughs.

These transformative platforms, driven by antibody engineering, are poised to revolutionize the treatment of major chronic inflammatory and oncological diseases.

These transformative platforms, driven by antibody engineering, are poised to revolutionize the treatment of major chronic inflammatory and oncological diseases.

OncoOne's oxMIF

READ NEXT

OncoOne's Technology Platforms Anti-oxMIF and PreTarg-it®

Home